169 related articles for article (PubMed ID: 18217949)
1. Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2.
Xue SA; Bendle GM; Holler A; Stauss HJ
Immunology; 2008 Jul; 124(3):315-21. PubMed ID: 18217949
[TBL] [Abstract][Full Text] [Related]
2. CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Ghorashian S; Veliça P; Chua I; McNicol AM; Carpenter B; Holler A; Nicholson E; Ahmadi M; Zech M; Xue SA; Uckert W; Morris E; Chakraverty R; Stauss HJ
J Immunol; 2015 Feb; 194(3):1080-9. PubMed ID: 25539815
[TBL] [Abstract][Full Text] [Related]
3. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
[TBL] [Abstract][Full Text] [Related]
4. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.
Mayr C; Bund D; Schlee M; Bamberger M; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2006 Jan; 34(1):44-53. PubMed ID: 16413390
[TBL] [Abstract][Full Text] [Related]
5. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
Kono M; Kumai T; Hayashi R; Yamaki H; Komatsuda H; Wakisaka R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Kobayashi H; Harabuchi Y
Cancer Immunol Immunother; 2021 Dec; 70(12):3421-3434. PubMed ID: 33866408
[TBL] [Abstract][Full Text] [Related]
6. A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function.
Bendle GM; Xue SA; Holler A; Stauss HJ
PLoS One; 2007 Apr; 2(4):e353. PubMed ID: 17406677
[TBL] [Abstract][Full Text] [Related]
7. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance.
Hubert FX; Kinkel SA; Davey GM; Phipson B; Mueller SN; Liston A; Proietto AI; Cannon PZ; Forehan S; Smyth GK; Wu L; Goodnow CC; Carbone FR; Scott HS; Heath WR
Blood; 2011 Sep; 118(9):2462-72. PubMed ID: 21505196
[TBL] [Abstract][Full Text] [Related]
8. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.
Voss RH; Kuball J; Engel R; Guillaume P; Romero P; Huber C; Theobald M
Immunol Res; 2006; 34(1):67-87. PubMed ID: 16720899
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein.
Antonia SJ; Geiger T; Miller J; Flavell RA
Int Immunol; 1995 May; 7(5):715-25. PubMed ID: 7547699
[TBL] [Abstract][Full Text] [Related]
10. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
Wiede F; Ziegler A; Zehn D; Tiganis T
J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
[TBL] [Abstract][Full Text] [Related]
11. Deletion of high-avidity T cells by thymic epithelium.
Hoffmann MW; Heath WR; Ruschmeyer D; Miller JF
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9851-5. PubMed ID: 7568231
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.
Zal T; Volkmann A; Stockinger B
J Exp Med; 1994 Dec; 180(6):2089-99. PubMed ID: 7964486
[TBL] [Abstract][Full Text] [Related]
13. Ig-specific T cell receptor-transgenic T cells are not deleted in the thymus and are functional in vivo.
Granucci F; Rescigno M; Marconi G; Foti M; Ricciardi-Castagnoli P
J Exp Med; 1996 Jan; 183(1):203-13. PubMed ID: 8551224
[TBL] [Abstract][Full Text] [Related]
14. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
15. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
16. Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.
Bendle GM; Holler A; Downs AM; Xue SA; Stauss HJ
Expert Opin Biol Ther; 2005 Sep; 5(9):1183-92. PubMed ID: 16120049
[TBL] [Abstract][Full Text] [Related]
17. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
Pircher H; Bürki K; Lang R; Hengartner H; Zinkernagel RM
Nature; 1989 Nov; 342(6249):559-61. PubMed ID: 2573841
[TBL] [Abstract][Full Text] [Related]
18. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.
Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T
Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484
[TBL] [Abstract][Full Text] [Related]
19. Evidence for clonal deletion and clonal anergy after intrathymic antigen injection in a transplantation model.
Gillanders WE; Arima T; Tu F; Hansen TH; Flye MW
Transplantation; 1997 Oct; 64(8):1159-66. PubMed ID: 9355834
[TBL] [Abstract][Full Text] [Related]
20. Utilising T cell receptor transgenic mice to define mechanisms of maternal T cell tolerance in pregnancy.
Moldenhauer LM; Hayball JD; Robertson SA
J Reprod Immunol; 2010 Dec; 87(1-2):1-13. PubMed ID: 20615552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
